VAERS reports by lot

Merck Pneumococcal lot M026317: VAERS reports

33 VAERS reports list lot M026317 as a Merck Pneumococcal vaccine, received between 2016-10-20 and 2020-02-28. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
33%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3536%
General / Systemic (non-local)1414%
Musculoskeletal1313%
Allergic / Anaphylactic1010%
Neurological88%
Cardiac / Cardiovascular77%
Gastrointestinal44%
Dermatological (non-injection-site)33%
Thrombotic / Hematological11%
Respiratory11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Minnesota5
Nebraska5
Michigan3
New York3
New Mexico2
Indiana2
Wisconsin1
Missouri1
Maine1
Virginia1
Pennsylvania1
Ohio1

Reports by month received

2016-103
2016-117
2016-127
2017-011
2017-032
2017-041
2017-052
2017-062
2017-081
2017-091
2017-102
2017-111
2017-121
2018-021
2020-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.